Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RZ Tienen, officially Regionaal Ziekenhuis Heilig Hart Tienen, is an active regional general hospital in Belgium serving patients through multiple campuses and medical centers in and around Tienen and Aarschot. The organization provides broad secondary-care hospital services, including surgery, pediatrics, orthopedics, urology, psychiatry, maternity care, stroke care, obesity care, diagnostics, and outpatient specialist consultations. It is not a drug-development biotech or pharma company; rather, it is a provider organization focused on clinical care delivery and hospital-based diagnostics and treatment. The hospital reports more than 800 staff and about 150 physicians, and it is developing a new consolidated hospital campus in Tienen. RZ Tienen also participates in regional care collaborations and has highlighted innovation in areas such as AI-assisted prostate biopsy diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RZ Tienen Hospital.